CD274 and neoplasm: Chemoradiotherapy can increase the expression of PD-L1 in tumor cells, leading to the synergy of immune drugs and chemoradiotherapy, and additional PD-L1 expression may offset T cell activation through excessive consumption of PD-L1 antibodies, thus causing this difference (53).